Happy Memorial Day!
In honor of our fallen heroes, we celebrate National Mental Health Awareness Month. As many of our service men and women suffer from PTSD due to the sacrifices they’ve made for our country.
Studies show those who suffer from conditions such as PTSD, Anxiety and Depression have low anandamide levels, an endogenous cannabinoid our body makes.
Researchers at NYU Langone Medical Center have discovered a connection between the quantity of cannabinoid receptors in the human brain, known as CB1 receptors, and post-traumatic stress disorder.
Results showed that participants with PTSD had more CB1 receptors in brain regions associated with fear and anxiety than volunteers without PTSD.
The PTSD group also had lower levels of the neurotransmitter anandamide, an endocannabinoid that binds to CB1. If anandamide levels are too low, Dr. Neumeister explains, the brain compensates by increasing the number of CB1 receptors. “This helps the brain utilize the remaining endocannabinoids,” he says.
Studies show CBD increases our natural anandamide levels by inhibiting FAAH, the enzyme responsible for breaking down anandamide.
When it comes to treating depression, CBD does appear to have many benefits over antidepressant medications.
Most antidepressant medications take weeks to start working. However a 2019 animal study found that CBD has a fast and sustained antidepressant-like effect.
CBD also results in fewer side effects than antidepressant medication. Insomnia, sexual dysfunction, mood swings, and agitation are common side effects of antidepressants. CBD has not shown similar issues.
Here’s more information and research on the subject:
For quality CBD products visit shop.drcarlie.com